Literature DB >> 30609250

The interplay between viruses and TRIM family proteins.

Ramisha Khan1, Amna Khan2, Amjad Ali1,3, Muhammad Idrees1,4.   

Abstract

Novel therapeutic options are urgently needed to improve the global treatment of viral infections. Tripartite motif (TRIM) family proteins are involved in various biological and cellular functions including differentiation, development, proliferation, oncogenesis, innate immunity, and viral autophagy. Various TRIM proteins show antiviral properties against different viral infections and are now transitioning from ubiquitin proteins to an efficient and emerging therapeutic class of proteins. TRIM proteins combat viruses by targeting them at pre/post transcription levels. This review summarizes the comprehensive roles of different TRIM proteins along with their expression systems and their applications towards antiviral therapeutics.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  HBV; HCV; HIV; HPV; HSV; IAV; MLV; TRIM; family; interplay; therapeutics

Mesh：

Substances：

Year:  2019        PMID： 30609250     DOI： 10.1002/rmv.2028

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN： 1052-9276            Impact factor:   6.989


  17 in total

1.  MicroRNA-376b-3p Promotes Porcine Reproductive and Respiratory Syndrome Virus Replication by Targeting Viral Restriction Factor TRIM22.

Authors:  Jing Chen; Shijie Zhao; Zhiying Cui; Wen Li; Pengli Xu; Huimin Liu; Xinyong Miao; Yu Chen; Fangfang Han; Hongying Zhang; Pingan Xia; Yina Zhang
Journal:  J Virol       Date:  2021-11-10       Impact factor: 6.549

2.  Tripartite-motif family protein 35-28 regulates microglia development by preventing necrotic death of microglial precursors in zebrafish.

Authors:  Tao Yu; Haoyue Kuang; Jiahao Chen; Xi Lin; Yi Wu; Keyu Chen; Mingjie Zhang; Wenqing Zhang; Zilong Wen
Journal:  J Biol Chem       Date:  2020-05-12       Impact factor: 5.157

3.  Human TRIM14 protects transgenic mice from influenza A viral infection without activation of other innate immunity pathways.

Authors:  Valentina V Nenasheva; Natalia A Nikitenko; Ekaterina A Stepanenko; Irina V Makarova; Lyudmila E Andreeva; Galina V Kovaleva; Andrey A Lysenko; Amir I Tukhvatulin; Denis Y Logunov; Vyacheslav Z Tarantul
Journal:  Genes Immun       Date:  2021-04-16       Impact factor: 2.676

4.  Inhibition of Antiviral Innate Immunity by Avibirnavirus VP3 via Blocking TBK1-TRAF3 Complex Formation and IRF3 Activation.

Authors:  Tingjuan Deng; Boli Hu; Xingbo Wang; Lulu Lin; Jianwei Zhou; Yuting Xu; Yan Yan; Xiaojuan Zheng; Jiyong Zhou
Journal:  mSystems       Date:  2021-05-11       Impact factor: 6.496

5.  TRIM24 facilitates antiviral immunity through mediating K63-linked TRAF3 ubiquitination.

Authors:  Qingchen Zhu; Tao Yu; Shucheng Gan; Yan Wang; Yifei Pei; Qifan Zhao; Siyu Pei; Shumeng Hao; Jia Yuan; Jing Xu; Fajian Hou; Xuefeng Wu; Chao Peng; Ping Wu; Jun Qin; Yichuan Xiao
Journal:  J Exp Med       Date:  2020-07-06       Impact factor: 14.307

Review 6.  TRIM Proteins in Host Defense and Viral Pathogenesis.

Authors:  Maria I Giraldo; Adam Hage; Sarah van Tol; Ricardo Rajsbaum
Journal:  Curr Clin Microbiol Rep       Date:  2020-08-08

Review 7.  Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.

Authors:  Sajad Fakhri; Zeinab Nouri; Seyed Zachariah Moradi; Esra Küpeli Akkol; Sana Piri; Eduardo Sobarzo-Sánchez; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

Review 8.  Tumor suppressor p53 cross-talks with TRIM family proteins.

Authors:  Juan Liu; Cen Zhang; Xue Wang; Wenwei Hu; Zhaohui Feng
Journal:  Genes Dis       Date:  2020-07-16

Review 9.  The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases.

Authors:  Pardis Mohammadi Pour; Sajad Fakhri; Sedigheh Asgary; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810

10.  Human cytomegalovirus evades ZAP detection by suppressing CpG dinucleotides in the major immediate early 1 gene.

Authors:  Yao-Tang Lin; Stephen Chiweshe; Dominique McCormick; Anna Raper; Arthur Wickenhagen; Victor DeFillipis; Eleanor Gaunt; Peter Simmonds; Sam J Wilson; Finn Grey
Journal:  PLoS Pathog       Date:  2020-09-04       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.